vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and RXO, Inc. (RXO). Click either name above to swap in a different company.

RXO, Inc. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.5× Alignment Healthcare, Inc.). Alignment Healthcare, Inc. runs the higher net margin — -1.1% vs -3.1%, a 2.0% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs -11.9%). RXO, Inc. produced more free cash flow last quarter ($-9.0M vs $-55.4M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 26.8%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.

ALHC vs RXO — Head-to-Head

Bigger by revenue
RXO
RXO
1.5× larger
RXO
$1.5B
$1.0B
ALHC
Growing faster (revenue YoY)
ALHC
ALHC
+56.3% gap
ALHC
44.4%
-11.9%
RXO
Higher net margin
ALHC
ALHC
2.0% more per $
ALHC
-1.1%
-3.1%
RXO
More free cash flow
RXO
RXO
$46.4M more FCF
RXO
$-9.0M
$-55.4M
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
26.8%
RXO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALHC
ALHC
RXO
RXO
Revenue
$1.0B
$1.5B
Net Profit
$-11.0M
$-46.0M
Gross Margin
Operating Margin
-1.0%
-2.9%
Net Margin
-1.1%
-3.1%
Revenue YoY
44.4%
-11.9%
Net Profit YoY
64.6%
-84.0%
EPS (diluted)
$-0.04
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
RXO
RXO
Q4 25
$1.0B
$1.5B
Q3 25
$993.7M
$1.4B
Q2 25
$1.0B
$1.4B
Q1 25
$926.9M
$1.4B
Q4 24
$701.2M
$1.7B
Q3 24
$692.4M
$1.0B
Q2 24
$681.3M
$930.0M
Q1 24
$628.6M
$913.0M
Net Profit
ALHC
ALHC
RXO
RXO
Q4 25
$-11.0M
$-46.0M
Q3 25
$3.7M
$-14.0M
Q2 25
$15.7M
$-9.0M
Q1 25
$-9.1M
$-31.0M
Q4 24
$-31.1M
$-25.0M
Q3 24
$-26.4M
$-243.0M
Q2 24
$-24.0M
$-7.0M
Q1 24
$-46.5M
$-15.0M
Operating Margin
ALHC
ALHC
RXO
RXO
Q4 25
-1.0%
-2.9%
Q3 25
0.8%
-0.5%
Q2 25
2.2%
Q1 25
-0.6%
-2.1%
Q4 24
-3.2%
-1.4%
Q3 24
-2.8%
-1.9%
Q2 24
-2.7%
Q1 24
-6.5%
-1.3%
Net Margin
ALHC
ALHC
RXO
RXO
Q4 25
-1.1%
-3.1%
Q3 25
0.4%
-1.0%
Q2 25
1.5%
-0.6%
Q1 25
-1.0%
-2.2%
Q4 24
-4.4%
-1.5%
Q3 24
-3.8%
-23.4%
Q2 24
-3.5%
-0.8%
Q1 24
-7.4%
-1.6%
EPS (diluted)
ALHC
ALHC
RXO
RXO
Q4 25
$-0.04
$-0.28
Q3 25
$0.02
$-0.08
Q2 25
$0.07
$-0.05
Q1 25
$-0.05
$-0.18
Q4 24
$-0.15
$-0.17
Q3 24
$-0.14
$-1.81
Q2 24
$-0.13
$-0.06
Q1 24
$-0.25
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
RXO
RXO
Cash + ST InvestmentsLiquidity on hand
$604.2M
$17.0M
Total DebtLower is stronger
$323.2M
$387.0M
Stockholders' EquityBook value
$179.3M
$1.5B
Total Assets
$1.1B
$3.3B
Debt / EquityLower = less leverage
1.80×
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
RXO
RXO
Q4 25
$604.2M
$17.0M
Q3 25
$644.1M
$25.0M
Q2 25
$503.8M
$18.0M
Q1 25
$479.5M
$16.0M
Q4 24
$470.6M
$35.0M
Q3 24
$381.0M
$55.0M
Q2 24
$363.7M
$7.0M
Q1 24
$301.7M
$7.0M
Total Debt
ALHC
ALHC
RXO
RXO
Q4 25
$323.2M
$387.0M
Q3 25
$322.7M
$387.0M
Q2 25
$322.3M
$387.0M
Q1 25
$321.9M
$387.0M
Q4 24
$321.4M
$351.0M
Q3 24
$212.0M
$352.0M
Q2 24
$211.7M
$370.0M
Q1 24
$162.0M
$351.0M
Stockholders' Equity
ALHC
ALHC
RXO
RXO
Q4 25
$179.3M
$1.5B
Q3 25
$161.9M
$1.6B
Q2 25
$141.0M
$1.6B
Q1 25
$108.1M
$1.6B
Q4 24
$99.9M
$1.6B
Q3 24
$114.5M
$1.7B
Q2 24
$123.7M
$579.0M
Q1 24
$130.9M
$582.0M
Total Assets
ALHC
ALHC
RXO
RXO
Q4 25
$1.1B
$3.3B
Q3 25
$1.1B
$3.2B
Q2 25
$1.0B
$3.2B
Q1 25
$895.6M
$3.3B
Q4 24
$782.1M
$3.4B
Q3 24
$692.3M
$3.4B
Q2 24
$716.3M
$1.8B
Q1 24
$633.2M
$1.8B
Debt / Equity
ALHC
ALHC
RXO
RXO
Q4 25
1.80×
0.25×
Q3 25
1.99×
0.24×
Q2 25
2.29×
0.24×
Q1 25
2.98×
0.24×
Q4 24
3.22×
0.22×
Q3 24
1.85×
0.21×
Q2 24
1.71×
0.64×
Q1 24
1.24×
0.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
RXO
RXO
Operating Cash FlowLast quarter
$-50.4M
$7.0M
Free Cash FlowOCF − Capex
$-55.4M
$-9.0M
FCF MarginFCF / Revenue
-5.5%
-0.6%
Capex IntensityCapex / Revenue
0.5%
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$113.1M
$-8.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
RXO
RXO
Q4 25
$-50.4M
$7.0M
Q3 25
$144.6M
$23.0M
Q2 25
$29.1M
$23.0M
Q1 25
$16.6M
$-2.0M
Q4 24
$-8.7M
$-7.0M
Q3 24
$26.2M
$-7.0M
Q2 24
$23.5M
$-5.0M
Q1 24
$-6.2M
$7.0M
Free Cash Flow
ALHC
ALHC
RXO
RXO
Q4 25
$-55.4M
$-9.0M
Q3 25
$139.1M
$9.0M
Q2 25
$21.1M
$9.0M
Q1 25
$8.4M
$-17.0M
Q4 24
$-18.0M
$-19.0M
Q3 24
$16.9M
$-18.0M
Q2 24
$11.8M
$-16.0M
Q1 24
$-17.4M
$-4.0M
FCF Margin
ALHC
ALHC
RXO
RXO
Q4 25
-5.5%
-0.6%
Q3 25
14.0%
0.6%
Q2 25
2.1%
0.6%
Q1 25
0.9%
-1.2%
Q4 24
-2.6%
-1.1%
Q3 24
2.4%
-1.7%
Q2 24
1.7%
-1.7%
Q1 24
-2.8%
-0.4%
Capex Intensity
ALHC
ALHC
RXO
RXO
Q4 25
0.5%
1.1%
Q3 25
0.6%
1.0%
Q2 25
0.8%
1.0%
Q1 25
0.9%
1.0%
Q4 24
1.3%
0.7%
Q3 24
1.3%
1.1%
Q2 24
1.7%
1.2%
Q1 24
1.8%
1.2%
Cash Conversion
ALHC
ALHC
RXO
RXO
Q4 25
Q3 25
38.77×
Q2 25
1.86×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

RXO
RXO

Retail Sector$546.0M37%
Last Mile$298.0M20%
Food And Beverage Sector$225.0M15%
Other Sector$185.0M13%
Managed Transportation$133.0M9%
Automotive Sector$93.0M6%

Related Comparisons